Advertisement

Index by author

November 01, 1993; Volume 267,Issue 2

  1. Abercrombie, E D

    1. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
      D Jackson, E D Abercrombie and M J Zigmond
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 912-918;

  2. Adams, R

    1. 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
      R W Kuncl, D B Drachman, R Adams and M Lehar
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 582-589;

  3. Adler, M W

    1. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids.
      I Szabo, M Rojavin, J L Bussiere, T K Eisenstein, M W Adler and T J Rogers
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 703-706;

  4. Alexandre, I

    1. Effects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells.
      C Michiels, T Arnould, D Janssens, I Alexandre, A Houbion and J Remacle
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 904-911;

  5. Arimura, A

    1. Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.
      W A Banks, A J Kastin, G Komaki and A Arimura
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 690-696;

  6. Arnould, T

    1. Effects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells.
      C Michiels, T Arnould, D Janssens, I Alexandre, A Houbion and J Remacle
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 904-911;

  7. Bakry, N

    1. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
      L L Simpson, J A Coffield and N Bakry
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 720-727;

  8. Banks, W A

    1. Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.
      W A Banks, A J Kastin, G Komaki and A Arimura
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 690-696;

  9. Barbanti, G

    1. Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.
      S Giuliani, R Patacchini, G Barbanti, D Turini, P Rovero, L Quartara, A Giachetti and C A Maggi
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 590-595;

  10. Bell-quilley, C P

    1. Renovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.
      C P Bell-Quilley, Y S Lin, S D Hilchey, E D Drugge and J C McGiff
      Journal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 676-682;
« Previous (Pages : 1 2 3 4 5 6 ... 26) Next »
Back to top

In this issue

Advertisement